Koen Poesen

4.5k total citations
69 papers, 1.4k citations indexed

About

Koen Poesen is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Koen Poesen has authored 69 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Neurology and 19 papers in Physiology. Recurrent topics in Koen Poesen's work include Alzheimer's disease research and treatments (18 papers), Amyotrophic Lateral Sclerosis Research (14 papers) and Dementia and Cognitive Impairment Research (11 papers). Koen Poesen is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Amyotrophic Lateral Sclerosis Research (14 papers) and Dementia and Cognitive Impairment Research (11 papers). Koen Poesen collaborates with scholars based in Belgium, United States and Netherlands. Koen Poesen's co-authors include Philip Van Damme, Kristl G. Claeys, Maxim De Schaepdryver, Rik Vandenberghe, Benjamin Gille, Jolien Schaeverbeke, Ludo Van Den Bosch, Xavier Bossuyt, Lieselot Dedeene and Jos Tournoy and has published in prestigious journals such as Circulation, Brain and Neurology.

In The Last Decade

Koen Poesen

65 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Koen Poesen 539 382 322 306 178 69 1.4k
Axel Regeniter 614 1.1× 377 1.0× 272 0.8× 136 0.4× 133 0.7× 41 1.5k
André Huss 702 1.3× 596 1.6× 463 1.4× 153 0.5× 257 1.4× 39 1.9k
Hans Hartung 396 0.7× 375 1.0× 314 1.0× 104 0.3× 96 0.5× 56 2.0k
Åsa Sandelius 440 0.8× 334 0.9× 223 0.7× 102 0.3× 134 0.8× 18 1.1k
Ananth K. Vellimana 557 1.0× 195 0.5× 162 0.5× 131 0.4× 106 0.6× 65 1.4k
Leslie Bridges 834 1.5× 887 2.3× 490 1.5× 246 0.8× 115 0.6× 78 2.4k
Jaime Ramos‐Cejudo 236 0.4× 518 1.4× 263 0.8× 405 1.3× 136 0.8× 44 1.6k
Kojiro Wada 931 1.7× 336 0.9× 241 0.7× 90 0.3× 68 0.4× 153 1.9k
István Bódi 827 1.5× 549 1.4× 378 1.2× 461 1.5× 170 1.0× 111 2.0k
Franz Blaes 928 1.7× 202 0.5× 524 1.6× 101 0.3× 136 0.8× 76 1.9k

Countries citing papers authored by Koen Poesen

Since Specialization
Citations

This map shows the geographic impact of Koen Poesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Poesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Poesen more than expected).

Fields of papers citing papers by Koen Poesen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen Poesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Poesen. The network helps show where Koen Poesen may publish in the future.

Co-authorship network of co-authors of Koen Poesen

This figure shows the co-authorship network connecting the top 25 collaborators of Koen Poesen. A scholar is included among the top collaborators of Koen Poesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen Poesen. Koen Poesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thal, Dietmar Rudolf, et al.. (2025). Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers. Molecular Neurodegeneration. 20(1). 33–33. 7 indexed citations
2.
Meyer, Steffi De, Jolien Schaeverbeke, Katarzyna Adamczuk, et al.. (2025). Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(1). e70071–e70071. 2 indexed citations
3.
Gagliardi, Delia, Mafalda Rizzuti, Pegah Masrori, et al.. (2024). Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS. Journal of Neurology. 271(12). 7557–7571. 3 indexed citations
4.
Meyer, Steffi De, Jolien Schaeverbeke, Emma S. Luckett, et al.. (2024). Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET. Brain Communications. 6(4). fcae162–fcae162. 9 indexed citations
5.
Dupont, Jolan, Maxim De Schaepdryver, Koen Poesen, et al.. (2023). Are inflammatory markers associated with sarcopenia-related traits in older adults with sarcopenia? – A cross-sectional analysis of the ENHANce study. Experimental Gerontology. 178. 112196–112196. 18 indexed citations
6.
Meyer, Steffi De, Jolien Schaeverbeke, Mariska Reinartz, et al.. (2023). Serum biomarkers for prognosis and monitoring in asymptomatic Alzheimer’s Disease. Alzheimer s & Dementia. 19(S14). 1 indexed citations
7.
Vanbrabant, Jeroen, Steffi De Meyer, Carrie E. Rubel, et al.. (2023). Performance of plasma pTau181 and pTau217 measured with fully automated LUMIPULSE G prototype immunoassays. Alzheimer s & Dementia. 19(S15). 1 indexed citations
8.
Schaepdryver, Maxim De, Pegah Masrori, Philip Van Damme, & Koen Poesen. (2022). Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis. CNS Neuroscience & Therapeutics. 29(1). 70–77. 4 indexed citations
9.
Schaepdryver, Maxim De, et al.. (2022). Biochemical and clinical biomarkers in adult SMA 3–4 patients treated with nusinersen for 22 months. Annals of Clinical and Translational Neurology. 9(8). 1241–1251. 30 indexed citations
10.
Masrori, Pegah, Simona Ospitalieri, Karin Forsberg, et al.. (2022). Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation. European Journal of Neurology. 29(4). 1279–1283. 3 indexed citations
11.
Vulsteke, Jean‐Baptiste, Xavier Bossuyt, Kristl G. Claeys, et al.. (2021). Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review. Seminars in Arthritis and Rheumatism. 51(2). 486–494. 10 indexed citations
12.
Schaepdryver, Maxim De, Steffi De Meyer, Andreas Jeromin, et al.. (2019). Serum neurofilament heavy chains as early marker of motor neuron degeneration. Annals of Clinical and Translational Neurology. 6(10). 1971–1979. 35 indexed citations
13.
Poesen, Koen, et al.. (2019). Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients. Acta Neurologica Belgica. 119(1). 29–36. 12 indexed citations
14.
Bossuyt, Xavier, Thibaut Belmondo, Ellen De Langhe, et al.. (2019). Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios. Autoimmunity Reviews. 18(11). 102386–102386. 19 indexed citations
15.
Gille, Benjamin, Maxim De Schaepdryver, Lieselot Dedeene, et al.. (2018). Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. Neuropathology and Applied Neurobiology. 45(3). 291–304. 90 indexed citations
16.
Bossuyt, Xavier, Koen Poesen, Kristl G. Claeys, et al.. (2017). FRI0393 Prevalence of myositis-specific antibodies in idiopathic inflammatory myopathy compared to disease and healthy controls. Annals of the Rheumatic Diseases. 76. 636–637. 1 indexed citations
17.
Ruysscher, Dirk De, et al.. (2015). A case report of an atypical POEMS syndrome. 6(4). 156–161. 1 indexed citations
18.
Tmimi, Layth Al, Jan Van Hemelrijck, Marc Van de Velde, et al.. (2015). Xenon anaesthesia for patients undergoing off-pump coronary artery bypass graft surgery: a prospective randomized controlled pilot trial. British Journal of Anaesthesia. 115(4). 550–559. 38 indexed citations
19.
Verheyen, A., Eve Peeraer, Diether Lambrechts, et al.. (2013). Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies. Neuroscience. 244. 77–89. 52 indexed citations
20.
Poesen, Koen, Thierry Janssens, Diether Lambrechts, Peter Carmeliet, & Edward M. Conway. (2008). Advantages of the Vegf Inhibitor, Macugen: A More Favourable Toxicity Profile. Investigative Ophthalmology & Visual Science. 49(13). 3412–3412. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Axel Regeniter Breakdown of academic impact, for papers by André Huss Breakdown of academic impact, for papers by Hans Hartung Breakdown of academic impact, for papers by Åsa Sandelius Breakdown of academic impact, for papers by Ananth K. Vellimana Breakdown of academic impact, for papers by Leslie Bridges Breakdown of academic impact, for papers by Jaime Ramos‐Cejudo Breakdown of academic impact, for papers by Kojiro Wada Breakdown of academic impact, for papers by István Bódi Breakdown of academic impact, for papers by Franz Blaes
Rankless by CCL
2026